Medigate vs. Armis
Medigate is no longer an independent product, or even a standalone product line. Claroty acquired Medigate in 2022, and its clinical device security capability has since been unified into Claroty xDome for Healthcare — the Medigate name no longer refers to a distinct offering. A 2026 evaluation isn't really Medigate the standalone startup against Armis; it's Claroty's healthcare-focused xDome module, built on Medigate's original clinical device technology, against Armis's converged enterprise asset intelligence approach. That distinction changes what you're actually deciding between, and it's worth knowing before a sales call references a product name that no longer exists on its own.
| Criteria | Claroty xDome for Healthcare | Armis |
|---|---|---|
| Platform | ||
| Primary orientation | Clinical device security, purpose-built for healthcare delivery organizations, now part of Claroty's CPS platform | Agentless enterprise asset intelligence, expanded from IT into healthcare, OT, and IoT |
| Platform scope | Healthcare-first; broader OT/IoT reach available via Claroty's wider xDome platform | IT, OT, IoT, healthcare — single converged platform by design |
| Market fit | Health delivery organizations, hospital systems, clinical environments | Enterprise — strongest where IT, OT, IoT, and healthcare coexist at scale |
| Deployment model | Passive network monitoring, purpose-built for clinical network segments | Agentless, cloud-based; passive traffic analysis and device fingerprinting |
| Technical | ||
| Clinical device classification | Deep — purpose-built clinical device taxonomy and risk context developed specifically for healthcare delivery environments | Broad healthcare device visibility as part of a wider asset intelligence model, not a clinical-first taxonomy |
| IT asset coverage | Not a primary focus; healthcare-first product line | Full IT asset intelligence — among the strongest IT device coverage in the category |
| OT coverage | Available through the broader Claroty platform rather than the Medigate product line specifically | Present across OT environments as part of converged coverage |
| Vulnerability management | Clinical-context risk scoring, factoring patient safety impact | Broad across IT, OT, IoT, and healthcare device types |
| Integration and compliance | ||
| Healthcare compliance evidence | Strong — HIPAA, FDA premarket/postmarket guidance context built into clinical risk model | Compliance coverage present but not healthcare-specific by origin |
| SIEM / SOAR integration | Supported, consistent with Claroty's broader integration library | Strong — broad integration library with IT security ecosystem emphasis |
| Procurement | ||
| Professional services | Required for deployment | Required for deployment |
| Pricing | $$$ — quote only | $$$ — quote only |
| Watch | Medigate as a standalone name no longer applies — the technology is now sold as Claroty xDome for Healthcare. Confirm current packaging and pricing directly, since post-acquisition product integration can continue shifting. | — |
Capability details reflect publicly available vendor materials as of this writing. Given Medigate's ongoing integration into Claroty's platform, confirm current product structure and naming directly with the vendor before evaluation.
Claroty xDome for Healthcare wins when
- Clinical device visibility and risk context, purpose-built for healthcare, is the primary requirement
- Your organization is a hospital system or health delivery organization where clinical network segmentation is the core problem
- HIPAA and FDA-context risk scoring for medical devices matters more than broad IT asset coverage
- You're already invested in, or evaluating, Claroty's broader xDome platform and want the healthcare-specific module
Armis wins when
- Your environment is genuinely converged — IT, OT, IoT, and healthcare at comparable scale — and you need one platform across all four
- IT asset intelligence is as important as clinical device visibility
- Your security team sits in IT and needs the platform to fit an IT-centric security operations model
- You want a single vendor relationship rather than a healthcare-specific product within a larger platform
The real decision
Because Medigate's technology is now sold as Claroty xDome for Healthcare rather than as an independent product, this comparison is really about depth versus breadth within healthcare security specifically. The clinical device taxonomy and risk model that made Medigate distinctive didn't disappear when the company was acquired — it's the foundation of xDome for Healthcare today. Armis's advantage is that healthcare is one part of a genuinely converged platform, which matters if your environment spans well beyond clinical devices into broad IT and OT territory.
If you're a health delivery organization whose primary exposure is clinical devices and you want the deepest purpose-built classification available, Claroty xDome for Healthcare remains the more specialized choice. If healthcare is one part of a broader converged IT/OT/IoT environment, Armis's single-platform approach may reduce vendor overhead. Either way, don't reference "Medigate" as a standalone product in vendor conversations — ask specifically about xDome for Healthcare, since sales materials and analyst notes referencing the old name are likely out of date. Use the RFP Evaluation Kit to structure that conversation.
Related comparisons: Claroty vs. Armis · Dragos vs. Claroty · Nozomi vs. Claroty